252 related articles for article (PubMed ID: 29789222)
1. Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: A systematic review and meta-analysis.
Fazleen NE; Whittaker M; Mamun A
Diabetes Metab Syndr; 2018 Nov; 12(6):1083-1090. PubMed ID: 29789222
[TBL] [Abstract][Full Text] [Related]
2. The association between metabolic syndrome and polycystic ovary syndrome: A systematic review and meta-analysis.
Otaghi M; Azami M; Khorshidi A; Borji M; Tardeh Z
Diabetes Metab Syndr; 2019; 13(2):1481-1489. PubMed ID: 31336510
[TBL] [Abstract][Full Text] [Related]
3. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis.
Behboudi-Gandevani S; Amiri M; Bidhendi Yarandi R; Noroozzadeh M; Farahmand M; Rostami Dovom M; Ramezani Tehrani F
Clin Endocrinol (Oxf); 2018 Feb; 88(2):169-184. PubMed ID: 28930378
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Polycystic Ovary Syndrome and Metabolic Syndrome in Adolescents: a Systematic Review and Meta-analysis.
Fu L; Xie N; Qu F; Zhou J; Wang F
Reprod Sci; 2023 Jan; 30(1):28-40. PubMed ID: 35107824
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis.
Niksima SH; Odel NM; Khaki S; Ghanei Gheshlagh R; Fallahi A; Kurdi A
Diabetes Metab Syndr; 2019; 13(3):1911-1915. PubMed ID: 31235114
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression.
Lim SS; Kakoly NS; Tan JWJ; Fitzgerald G; Bahri Khomami M; Joham AE; Cooray SD; Misso ML; Norman RJ; Harrison CL; Ranasinha S; Teede HJ; Moran LJ
Obes Rev; 2019 Feb; 20(2):339-352. PubMed ID: 30339316
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: A systematic review and meta-analysis.
Khorshidi A; Azami M; Tardeh S; Tardeh Z
Diabetes Metab Syndr; 2019; 13(4):2747-2753. PubMed ID: 31405703
[TBL] [Abstract][Full Text] [Related]
8. Is ovarian volume a good predictor to determine metabolic syndrome development in polycystic ovary patients.
Sipahi M; Tokgöz VY; Keskin Ö; Atasever M; Menteşe A; Demir S
J Obstet Gynaecol; 2019 Apr; 39(3):372-376. PubMed ID: 30744441
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study.
Kyrkou G; Trakakis E; Attilakos A; Panagopoulos P; Chrelias C; Papadimitriou A; Vaggopoulos V; Alexiou E; Mastorakos G; Lykeridou A; Kassanos D; Papaevangelou V; Papantoniou N
Arch Gynecol Obstet; 2016 Apr; 293(4):915-23. PubMed ID: 26615602
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.
Li L; Feng Q; Ye M; He Y; Yao A; Shi K
J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375
[TBL] [Abstract][Full Text] [Related]
12. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
13. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
14. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
Gupta V; Mishra S; Mishra S; Gupta V
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
[TBL] [Abstract][Full Text] [Related]
15. Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.
Zhu S; Zhang B; Jiang X; Li Z; Zhao S; Cui L; Chen ZJ
Fertil Steril; 2019 Jan; 111(1):168-177. PubMed ID: 30611404
[TBL] [Abstract][Full Text] [Related]
16. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.
Barry JA; Azizia MM; Hardiman PJ
Hum Reprod Update; 2014; 20(5):748-58. PubMed ID: 24688118
[TBL] [Abstract][Full Text] [Related]
17. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
18. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
Moran LJ; Misso ML; Wild RA; Norman RJ
Hum Reprod Update; 2010; 16(4):347-63. PubMed ID: 20159883
[TBL] [Abstract][Full Text] [Related]
19. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.
Coviello AD; Legro RS; Dunaif A
J Clin Endocrinol Metab; 2006 Feb; 91(2):492-7. PubMed ID: 16249280
[TBL] [Abstract][Full Text] [Related]
20. Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis.
Escobar-Morreale HF; Roldán-Martín MB
Diabetes Care; 2016 Apr; 39(4):639-48. PubMed ID: 27208367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]